119 related articles for article (PubMed ID: 38000701)
1. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial.
Valdes G; Scholey J; Nano TF; Gennatas ED; Mohindra P; Mohammed N; Zeng J; Kotecha R; Rosen LR; Chang J; Tsai HK; Urbanic JJ; Vargas CE; Yu NY; Ungar LH; Eaton E; Simone CB
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):66-77. PubMed ID: 38000701
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
Gjyshi O; Xu T; Elhammali A; Boyce-Fappiano D; Chun SG; Gandhi S; Lee P; Chen AB; Lin SH; Chang JY; Tsao A; Gay CM; Zhu XR; Zhang X; Heymach JV; Fossella FV; Lu C; Nguyen QN; Liao Z
J Thorac Oncol; 2021 Feb; 16(2):269-277. PubMed ID: 33198942
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial.
Hoppe BS; Nichols RC; Flampouri S; Pankuch M; Morris CG; Pham DC; Mohindra P; Hartsell WF; Mohammed N; Chon BH; Kestin LL; Simone CB
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):732-741. PubMed ID: 35306151
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
Gomez DR; Gillin M; Liao Z; Wei C; Lin SH; Swanick C; Alvarado T; Komaki R; Cox JD; Chang JY
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):665-70. PubMed ID: 23688815
[TBL] [Abstract][Full Text] [Related]
6. Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Contreras J; Srivastava A; Samson P; DeWees T; Govindan R; Baggstrom MQ; Morgensztern D; Roach M; Badiyan SN; Bradley J; Waqar S; Robinson C
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):742-748. PubMed ID: 35074432
[TBL] [Abstract][Full Text] [Related]
7. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.
Bradley JA; Dagan R; Ho MW; Rutenberg M; Morris CG; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):411-421. PubMed ID: 26611875
[TBL] [Abstract][Full Text] [Related]
8. High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
Liu YE; Lin Q; Meng FJ; Chen XJ; Ren XC; Cao B; Wang N; Zong J; Peng Y; Ku YJ; Chen Y
Radiat Oncol; 2013 Aug; 8(1):198. PubMed ID: 23937855
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
10. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
[TBL] [Abstract][Full Text] [Related]
11. Ultra-fast pencil beam scanning proton therapy for locally advanced non-small-cell lung cancers: Field delivery within a single breath-hold.
Maradia V; van de Water S; Meer D; Weber DC; Lomax AJ; Psoroulas S
Radiother Oncol; 2022 Sep; 174():23-29. PubMed ID: 35788354
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
13. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
14. Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617.
Ladbury C; Li R; Danesharasteh A; Ertem Z; Tam A; Liu J; Hao C; Li R; McGee H; Sampath S; Williams T; Glaser S; Khasawneh M; Liao Z; Lee P; Ryckman J; Shaikh P; Amini A
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1287-1296. PubMed ID: 37406826
[TBL] [Abstract][Full Text] [Related]
15. A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.
Hoppe BS; Henderson R; Pham D; Cury JD; Bajwa A; Morris CG; D'Agostino H; Flampouri S; Huh S; Li Z; McCook B; Nichols RC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):517-522. PubMed ID: 26774428
[TBL] [Abstract][Full Text] [Related]
16. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
17. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
[TBL] [Abstract][Full Text] [Related]
18. Full Dose SBRT in Combination With Mediastinal Chemoradiation for Locally Advanced, Non-Small Cell Lung Cancer: A Practical Guide for Planning, Dosimetric Results From a Phase 2 Study, and a Treatment Planning Guide for the Phase 3 NRG Oncology LU-008 Trial.
Heinzerling JH; Pen OV; Robinson M; Foster R; Kelly B; Mileham KF; Moeller B; Prabhu RS; Corso C; Ward MW; Sullivan CM; Burri S; Simone CB
Pract Radiat Oncol; 2023; 13(6):531-539. PubMed ID: 37406774
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
